Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Net-Receivables" stands at 127.26 Billion Japanese Yens as of 09/30/2025, the highest value since 06/30/2022.
As of the end of Sumitomo Dainippon Pharma Co Ltd's second quarter, the item "Net Receivables" stands at 127.26 Billion JPY. This represents an increase of 47.76 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 84.74 percent compared to the value the year prior.
The 1 year change in percent is 84.74.
The 3 year change in percent is 10,058.60.
The 5 year change in percent is 9,152.16.
The 10 year change in percent is -36.08.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Net Receivables | 905,699,262,464.00 |
![]() | Johnson & Johnson - Net Receivables | 486,508,953,600.00 |
![]() | AbbVie Inc - Net Receivables | 399,570,305,024.00 |
![]() | Roche Holding AG - Net Receivables | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Net Receivables | 280,205,508,085.11 |